Increased numbers of circulating hematopoietic stem/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab. (Q36508862)
Jump to navigation
Jump to search
scientific article published on 14 January 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | Increased numbers of circulating hematopoietic stem/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab. |
scientific article published on 14 January 2008 |
Statements
Increased numbers of circulating hematopoietic stem/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab (English)
Annette Wundes
Kai-Hsin Chang
Sylvia Lucas
Thalia Papayannopoulou
14 January 2008
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference